Cerevel Therapeutics Hldg Stock (NASDAQ: CERE) stock price, news, charts, stock research, profile.
Open | $42.200 |
Close | $42.190 |
Volume / Avg. | 474.428K / 1.379M |
Day Range | 41.995 - 42.350 |
52 Wk Range | 19.590 - 43.590 |
Market Cap | $7.687B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 9.12% |
Days to Cover | 6.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ: CERE) through any online brokerage.
Other companies in Cerevel Therapeutics Hldg’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by Mizuho on Friday, February 16, 2024. The analyst firm set a price target for 45.00 expecting CERE to rise to within 12 months (a possible 6.66% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $42.19 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg’s Q1 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.